HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Alizadeh, H. Articles by Niederkorn, J. Y. Search for Related Content PubMed PubMed Citation Articles by Alizadeh, H. Articles by Niederkorn, J. Y.

Reduction of Liver Metastasis of Intraocular Melanoma by Interferon-ß Gene Transfer

¹From the Department of Ophthalmology, University of Texas Southwestern Medical Center, Dallas, Texas; and the ²Research Center, Societá Industria Farmaceutica Italiana, Societá per Azioni, Catania, Italy.

PURPOSE. This study determined whether adenovirus-mediated transfer of the murine interferon-ß (AdCMVIFN-ß) gene protects against liver metastases arising from intraocular melanomas in mice.

METHODS. A replication-deficient adenovirus vector (AdCMVIFN-ß) was used for the in vivo transfer of the murine IFN-ß gene into intraocular melanoma–bearing mice. AdCMVIFN-ß was injected either intravenously or directly into the intraocular melanomas. The effect of gene transfer on liver metastases was ascertained by histopathologic analysis of the livers and by measuring serum levels of aspartate aminotransferase (AST) and alanine aminotransferase (ALT), which are two enzymes associated with liver metastases in patients with uveal melanoma.

RESULTS. Mice treated with two intratumoral injections of AdCMVIFN-ß had a 68% reduction in metastatic liver lesions (P = 0.016) and a 51% reduction in liver enzyme levels compared with control mice (P = 0.02). However, the antimetastatic effect of AdCMVIFN-ß was not directly attributable to the adenovirus vector or virus-mediated cytolysis of tumor cells. Intravenous treatment with AdCMVIFN-ß resulted in an 86% reduction in the number of metastatic foci in the liver (P = 0.014) and a 61% reduction of serum AST levels compared with mice treated with AdCMVLacZ (P = 0.015). AdCMVIFN-ß treatment produced a sharp increase in the NK cell activity that was demonstrable in vivo and in vivo. In vivo depletion of NK cells by anti-asialo GM1 antibody abrogated the antimetastatic effects of AdCMVIFN-ß.

CONCLUSIONS. The results support the feasibility of activation of NK cell function through gene transfer as one possible therapeutic strategy for reducing hepatic metastases of uveal melanomas.

This article has been cited by other articles:

				Collaborative Ocular Melanoma Study Group* Development of Metastatic Disease After Enrollment in the COMS Trials for Treatment of Choroidal Melanoma: Collaborative Ocular Melanoma Study Group Report No. 26 Arch Ophthalmol, December 1, 2005; 123(12): 1639 - 1643. [Abstract] [Full Text] [PDF]

				H. Li, J. Y. Niederkorn, S. Neelam, E. Mayhew, R. A. Word, J. P. McCulley, and H. Alizadeh Immunosuppressive Factors Secreted by Human Amniotic Epithelial Cells Invest. Ophthalmol. Vis. Sci., March 1, 2005; 46(3): 900 - 907. [Abstract] [Full Text] [PDF]

				M. Diener-West, S. M. Reynolds, D. J. Agugliaro, R. Caldwell, K. Cumming, J. D. Earle, D. L. Green, B. S. Hawkins, J. Hayman, I. Jaiyesimi, et al. Screening for Metastasis From Choroidal Melanoma: The Collaborative Ocular Melanoma Study Group Report 23 J. Clin. Oncol., June 15, 2004; 22(12): 2438 - 2444. [Abstract] [Full Text] [PDF]

				D. H. Ren, E. Mayhew, C. Hay, H. Li, H. Alizadeh, and J. Y. Niederkorn Uveal Melanoma Expression of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Receptors and Susceptibility to TRAIL-Induced Apoptosis Invest. Ophthalmol. Vis. Sci., April 1, 2004; 45(4): 1162 - 1168. [Abstract] [Full Text] [PDF]